UK biotech Bicycle Therapeutics has raised £40 million ($52m) in a new funding round to help it progress its pipeline, including its lead compound, a first-in-class cancer treatment. The company ...

Legendary supercar builder Gordon Murray has plans beyond the T.50 and T.33 variants. In a recent appearance on Autocar podcast, Murray revealed that a new model built on a new architecture is ...

develop a model that can help municipalities choose optimal locations as they expand their cycling lane networks in response to growing demand.

All of this means it's unlikely Viking will upset the market's current leaders. That said, this newer biotech player could eventually carve out a spot if all continues to go well in clinical studies.

Bicycle's immuno-oncology pipeline is headed by BT7480, a tumour-targeted immune cell agonist (TICA) that binds to Nectin-4 on cancer cells and stimulates CD137 on immune cells, driving an immune ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

ARIZONA -- The Arizona Cardinals are set to play their season finale against the San Francisco 49ers later today at State Farm Stadium, and quarterback Kyler Murray is close to earning a $750,000 ...

33 GMA will then launch a different type of car boasting a new platform The U.K.'s Gordon Murray Automotive (GMA) will unveil a more track-focused “s” version as the third and final version of ...

Novak Djokovic has credited rival-turned-coach Andy Murray with bringing a “fresh look” to his game ahead of the start of the 2025 season. Having played Murray 36 times in ATP events and ...

Novak Djokovic has admitted he's not sure whether his partnership with Andy Murray will continue past the Australian Open, but a leading tennis expert has explained why it might be beneficial to ...

No Oxular employees are joining Regeneron, though several will be “helping short-term with tech transfer and transition work in consulting roles,” a Regeneron spokesperson told Fierce Biotech ...

GSK Plc CEO Emma Walmsley talks about buying US cancer biotech IDRx for as much as $1.15 billion ... aircraft entered Polish ...